Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curaleaf Holdings Inc (OP: CURLF )

2.960 +0.070 (+2.42%)
Streaming Delayed Price Updated: 3:59 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Curaleaf Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Aurora Cannabis Stock a Buy?
The company's cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
American Cannabis MSOs Portfolio Reversed Direction Last Week
This article highlights how each constituent in the Portfolio fared last week and MTD along with their reported Q1 profit or loss and their Q1 adjusted EBITDA as a percentage of quarterly revenue for... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf's Boris Jordan Says Rescheduling Cannabis Will Save Industry $200M In Revenue, Bring Illicit Market In From The Cold
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Undiscovered OTC Stocks to Buy for Multibagger Returns
These are the OTC stocks to buy as they represent undervalued companies with strong fundamentals and a healthy growth outlook. 
Via InvestorPlace
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pitch Your Cannabis Business And Win Thousands In Prizes At This Benzinga & Curaleaf Competition
The Benzinga Cannabis Capital Conference, in partnership with Curaleaf's (OTC: CURLF) corporate philanthropy arm, Rooted In Good, has launched the 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Breathalyzer Innovations Meet Rising Demand as Cannabis Market Booms
From Financial Buzz Media
Via GlobeNewswire
Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024
Cannabis stocks to buy could see higher highs on several key catalysts. In fact, here are three stocks you may want to buy today. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Largest Cannabis Co. Curaleaf's $1.5B Projected Revenue For 2025: Analyst Raises Rating To Outperform
Wedbush Securities released a report on Curaleaf Holdings, Inc. (OTC: CURLF), the largest U.S. cannabis company by market cap, raising the stock's 12-month price target to $7.00 from $6.00 and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more than $5 million, the ads are criss-crossing the state to bring attention to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
While it's uncertain if the Drug Enforcement Agency will reschedule marijuana, these are three cannabis stocks to watch if it does. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
Some of the most undervalued cannabis stocks could race to higher highs on several key catalysts this year. Here are seven. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
American Cannabis MSOs Portfolio Down 5% On The Week
Five of the 7 constituents released their Q1 financial reports earlier this week, contributing to a 5% decline in our portfolio for the week ending May 10. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Undiscovered Stocks to Buy for 3-Bagger Returns by 2025
Undiscovered stocks picks to buy represent undervalued ideas with strong fundamentals and a robust growth outlook. 
Via InvestorPlace
CURLF Stock Earnings: Curaleaf Holdings Misses EPS, Misses Revenue for Q1 2024
CURLF stock results show that Curaleaf Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf Holdings, Inc. (OTC: CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
Curaleaf has evolved from an MSO to an MCO, a multi-country operator, doing business in 15 countries worldwide with the expectation of creating further separation from their peers. 
Via Talk Markets
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Prohibitionist Group Says DEA Announcement on Cannabis Rescheduling Coming “Very Soon”
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.